Literature DB >> 20048145

p90 ribosomal S6 kinase 1 (RSK1) and the catalytic subunit of protein kinase A (PKA) compete for binding the pseudosubstrate region of PKAR1alpha: role in the regulation of PKA and RSK1 activities.

Xianlong Gao1, Deepti Chaturvedi, Tarun B Patel.   

Abstract

Previously we showed that the inactive form of p90 ribosomal S6 kinase 1 (RSK1) interacts with the regulatory subunit, PKARIalpha, of protein kinase A (PKA), whereas the active RSK1 interacts with the catalytic subunit (PKAc) of PKA. Herein, we demonstrate that the N-terminal kinase domain (NTK) of RSK1 is necessary for interactions with PKARIalpha. Substitution of the activation loop phosphorylation site (Ser-221) in the NTK with the negatively charged Asp residue abrogated the association between RSK1 and PKARIalpha. This explains the lack of an interaction between active RSK1 and PKARIalpha. Full-length RSK1 bound to PKARIalpha with an affinity of 0.8 nm. The NTK domain of RSK1 competed with PKAc for binding to the pseudosubstrate region (amino acids 93-99) of PKARIalpha. Overexpressed RSK1 dissociated PKAc from PKARIalpha, increasing PKAc activity, whereas silencing of RSK1 increased PKAc/PKARIalpha interactions and decreased PKAc activity. Unlike PKAc, which requires Arg-95 and -96 in the pseudosubstrate region of PKARIalpha for their interactions, RSK1/PKARIalpha association requires all four Arg residues (Arg-93-96) in the pseudosubstrate site of PKARIalpha. A peptide (Wt-PS) corresponding to residues 91-99 of PKARIalpha competed for binding of RSK1 with PKARIalpha both in vitro and in intact cells. Furthermore, peptide Wt-PS (but not control peptide Mut-PS), by dissociating RSK1 from PKARIalpha, activated RSK1 in the absence of any growth factors and protected cells from apoptosis. Thus, by competing for binding to the pseudosubstrate region of PKARIalpha, RSK1 regulates PKAc activity in a cAMP-independent manner, and PKARIalpha by associating with RSK1 regulates its activation and its biological functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048145      PMCID: PMC2844146          DOI: 10.1074/jbc.M109.083642

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Dynamics of signaling by PKA.

Authors:  Susan S Taylor; Choel Kim; Dominico Vigil; Nina M Haste; Jie Yang; Jian Wu; Ganesh S Anand
Journal:  Biochim Biophys Acta       Date:  2005-09-22

2.  Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.

Authors:  Jeffrey A Smith; Celeste E Poteet-Smith; Yaming Xu; Timothy M Errington; Sidney M Hecht; Deborah A Lannigan
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

3.  Regulation of protein kinase A activity by p90 ribosomal S6 kinase 1.

Authors:  Xianlong Gao; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

4.  Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase.

Authors:  Deepti Chaturvedi; Helen M Poppleton; Teresa Stringfield; Ann Barbier; Tarun B Patel
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

5.  Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types.

Authors:  Bettina A Dümmler; Camilla Hauge; Joachim Silber; Helger G Yntema; Lars S Kruse; Birte Kofoed; Brian A Hemmings; Dario R Alessi; Morten Frödin
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

6.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

7.  The PKARIalpha subunit of protein kinase A modulates the activation of p90RSK1 and its function.

Authors:  Deepti Chaturvedi; Michael S Cohen; Jack Taunton; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

8.  Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.

Authors:  Mari Ikuta; Maria Kornienko; Noel Byrne; John C Reid; Shinji Mizuarai; Hidehito Kotani; Sanjeev K Munshi
Journal:  Protein Sci       Date:  2007-10-26       Impact factor: 6.725

9.  PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.

Authors:  Choel Kim; Cecilia Y Cheng; S Adrian Saldanha; Susan S Taylor
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

Review 10.  The RSK factors of activating the Ras/MAPK signaling cascade.

Authors:  Audrey Carriere; Hind Ray; John Blenis; Philippe P Roux
Journal:  Front Biosci       Date:  2008-05-01
View more
  6 in total

1.  Interactions between the regulatory subunit of type I protein kinase A and p90 ribosomal S6 kinase1 regulate cardiomyocyte apoptosis.

Authors:  Xianlong Gao; Brian Lin; Sakthivel Sadayappan; Tarun B Patel
Journal:  Mol Pharmacol       Date:  2013-12-04       Impact factor: 4.436

2.  Protein kinase A is central for forward transport of two-pore domain potassium channels K2P3.1 and K2P9.1.

Authors:  Alexandra Mant; David Elliott; Patrick A Eyers; Ita M O'Kelly
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

3.  t-Darpp stimulates protein kinase A activity by forming a complex with its RI regulatory subunit.

Authors:  Dirk Theile; Shuhui Geng; Erin C Denny; Jamil Momand; Susan E Kane
Journal:  Cell Signal       Date:  2017-09-01       Impact factor: 4.315

4.  Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the β1-adrenergic receptor.

Authors:  Karen Dockstader; Karin Nunley; Anis Karimpour-Fard; Allen Medway; Penny Nelson; J David Port; Stephen B Liggett; Michael R Bristow; Carmen C Sucharov
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

5.  Localization and retention of p90 ribosomal S6 kinase 1 in the nucleus: implications for its function.

Authors:  Xianlong Gao; Deepti Chaturvedi; Tarun B Patel
Journal:  Mol Biol Cell       Date:  2011-11-30       Impact factor: 4.138

6.  Protein kinase A activation by the anti-cancer drugs ABT-737 and thymoquinone is caspase-3-dependent and correlates with platelet inhibition and apoptosis.

Authors:  Natalia Rukoyatkina; Elke Butt; Hariharan Subramanian; Viacheslav O Nikolaev; Igor Mindukshev; Ulrich Walter; Stepan Gambaryan; Peter M Benz
Journal:  Cell Death Dis       Date:  2017-06-29       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.